Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.

Serhan CN.

J Periodontol. 2008 Aug;79(8 Suppl):1520-6. doi: 10.1902/jop.2008.080231. Review.

PMID:
18673006
2.

Novel omega -- 3-derived local mediators in anti-inflammation and resolution.

Serhan CN.

Pharmacol Ther. 2005 Jan;105(1):7-21. Review.

PMID:
15626453
3.

New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.

Yacoubian S, Serhan CN.

Nat Clin Pract Rheumatol. 2007 Oct;3(10):570-9; quiz 1 p following 589. Review.

PMID:
17906612
4.

Resolvins and protectins in the termination program of acute inflammation.

Ariel A, Serhan CN.

Trends Immunol. 2007 Apr;28(4):176-83. Epub 2007 Mar 6. Review.

PMID:
17337246
5.

Anti-inflammatory and proresolving lipid mediators.

Serhan CN, Yacoubian S, Yang R.

Annu Rev Pathol. 2008;3:279-312. doi: 10.1146/annurev.pathmechdis.3.121806.151409. Review.

6.
7.

Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.

Serhan CN.

Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):157-63. doi: 10.1016/j.plefa.2008.09.012. Epub 2008 Nov 12. Review.

8.

Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer.

Janakiram NB, Rao CV.

Curr Mol Med. 2009 Jun;9(5):565-79. Review.

PMID:
19601807
9.

Novel chemical mediators in the resolution of inflammation: resolvins and protectins.

Serhan CN.

Anesthesiol Clin. 2006 Jun;24(2):341-64. Review.

PMID:
16927933
10.

Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.

Fredman G, Serhan CN.

Biochem J. 2011 Jul 15;437(2):185-97. doi: 10.1042/BJ20110327.

11.

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.

Serhan CN, Chiang N.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S200-15. Epub 2007 Oct 29. Review.

12.

Endogenous receptor agonists: resolving inflammation.

Bannenberg G, Arita M, Serhan CN.

ScientificWorldJournal. 2007 Sep 1;7:1440-62. Review.

13.

Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.

Norling LV, Serhan CN.

J Intern Med. 2010 Jul;268(1):15-24. doi: 10.1111/j.1365-2796.2010.02235.x. Epub 2010 Apr 28. Review.

14.

Resolvins: Current understanding and future potential in the control of inflammation.

Bannenberg GL.

Curr Opin Drug Discov Devel. 2009 Sep;12(5):644-58. Review. Erratum in: Curr Opin Drug Discov Devel. 2010 Jan;13(1):136.

PMID:
19736623
15.

Lipoxins and new lipid mediators in the resolution of inflammation.

Schwab JM, Serhan CN.

Curr Opin Pharmacol. 2006 Aug;6(4):414-20. Epub 2006 Jun 5. Review.

PMID:
16750421
16.

Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.

Serhan CN.

J Thromb Haemost. 2009 Jul;7 Suppl 1:44-8. doi: 10.1111/j.1538-7836.2009.03396.x. Review.

17.

[What the surgeon needs to know about basic new concepts of inflammation and their therapeutic consequences: sanitation of inflammation is not a passive but rather an active process regulated by lipid mediators].

Gardemann A, Meyer F, Braun-Dullaeus R.

Zentralbl Chir. 2013 Jun;138(3):322-30. doi: 10.1055/s-0032-1328182. Epub 2013 Jun 27. Review. German.

PMID:
23807584
18.

Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins.

Serhan CN.

Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):115-21. Review.

PMID:
15716788
19.

Lipoxins and resolvins in inflammatory bowel disease.

Weylandt KH, Kang JX, Wiedenmann B, Baumgart DC.

Inflamm Bowel Dis. 2007 Jun;13(6):797-9. Review.

PMID:
17262807
20.

Modulation of inflammatory cytokines by omega-3 fatty acids.

Kang JX, Weylandt KH.

Subcell Biochem. 2008;49:133-43. doi: 10.1007/978-1-4020-8831-5_5. Review.

PMID:
18751910

Supplemental Content

Support Center